Eagle Health Investments’s Terns Pharmaceuticals TERN Stock Holding History

Eagle Health Investments’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-412,497	Closed	-$21.7M	–	32
2026 Q1	$21.7M	Buy	412,497 +137,407	+50%	+$5.64M	3.8%	10
2025 Q4	$11.1M	Buy	+275,090	New	+$6.36M	2.44%	13

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eagle Health Investments's TERN Position: Q2 2026 in Review

Eagle Health Investments sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 412,497 shares — an estimated $21.7M sold.

Eagle Health Investments first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $21.7M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Eagle Health Investments reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Eagle Health Investments sold 412,497 Terns Pharmaceuticals shares in Q2 2026, an estimated $21.7M.
Eagle Health Investments first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Eagle Health Investments's Terns Pharmaceuticals position peaked at $21.7M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.